NCT00376532View on ClinicalTrials.gov

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
MyocardiopathiesIschemia, MyocardialArrythmiaDeath, Sudden, Cardiac
Trial Locations (1)

19107

Jefferson Heart Institute, Philadelphia

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Thomas Jefferson University

OTHER